• SCAI 2017 Late-Breaking Clinical Trials

    Your Late-Breaking Clinical Trial (LBCT) results belong at Interventional Cardiology's premiere education meeting.


    Here's Why:

    • Your Findings Will be Heard Loud and Clear
      SCAI will promote your clinical trial, in its robust media kit and to its extensive list of mainstream and trade journalists. Following your presentation, SCAI will publicize your findings on its websites directed to the Interventional Cardiology community as well as the general public. Late-Breaking Clinical Trials presented at SCAI's Scientific Sessions have been prominently featured in The Wall Street Journal, USA Today, The Washington Post, and The L.A. Times and more!

    • A Focus on Interventional Cardiology
      SCAI's attendees are exactly those you want your results to reach. And they won't be distracted by headliners from other subspecialties or general cardiology. You'll be in the best position to frame the discussion about what your trial means to the medical community.

    • Easy to Navigate
      SCAI 2017 Scientific Sessions is just the right size to foster collegial education, dialogue, and collaboration.

    • Impact Patient Care!
      Accepted Late-Breaking Clinical Trials (LBCT) will be presented in featured sessions and considered for simultaneous publication in CCI, with appropriate manuscript submission and review.


    Submission Terms and Conditions:


    Questions?

    Please contact Rachel Pham at RPham@scai.org .